新冠疫情之前及期间丁丙诺啡项目评估
A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic.
作者信息
Hageman Thomas M, Palmer Joshua, Mullick Prabir, Lee Heeyoung
出版信息
J Nurse Pract. 2022 Mar;18(3):267-271. doi: 10.1016/j.nurpra.2021.12.025. Epub 2022 Jan 5.
Abstract
This project evaluated the service delivery (ie, attendance rate) of a buprenorphine management treatment program and compared patient recovery-related information between service methods. This was a medical record review and cross-sectional comparison of pre-COVID-19 vs post onset of COVID-19 data. In the sample of 28 adults, mean attendance rates did not differ significantly before (99.46%) vs during the pandemic (96.13%; = 1.92, = .07). Patient participation in therapy before and during the pandemic did differ significantly (χ = 1.98, = .03). The use of telemental health services within a BMT program may be a viable option when normal in-person services are disrupted.
摘要
该项目评估了丁丙诺啡管理治疗项目的服务提供情况（即出勤率），并比较了不同服务方式下与患者康复相关的信息。这是一项对新冠肺炎疫情前与疫情爆发后数据进行的病历回顾和横断面比较。在28名成年人的样本中，疫情前的平均出勤率（99.46%）与疫情期间的平均出勤率（96.13%；t = 1.92，p = 0.07）差异不显著。疫情前和疫情期间患者参与治疗的情况确实存在显著差异（χ² = 1.98，p = 0.03）。当正常的面对面服务中断时，在丁丙诺啡维持治疗（BMT）项目中使用远程心理健康服务可能是一个可行的选择。
相似文献
1
A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic.新冠疫情之前及期间丁丙诺啡项目评估
J Nurse Pract. 2022 Mar;18(3):267-271. doi: 10.1016/j.nurpra.2021.12.025. Epub 2022 Jan 5.
2
Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic.新冠疫情期间 Medicaid 受助人阿片类药物使用障碍治疗参与度的变化趋势。
JAMA Health Forum. 2022 Mar 11;3(3):e220093. doi: 10.1001/jamahealthforum.2022.0093. eCollection 2022 Mar.
3
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.在 COVID-19 大流行期间，丁丙诺啡和纳曲酮控释制剂的种族和民族差异。
JAMA Netw Open. 2022 Jun 1;5(6):e2214765. doi: 10.1001/jamanetworkopen.2022.14765.
4
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.COVID-19 的影响以及快速放宽政策以扩大阿片类药物使用障碍（MOUD）药物获取：一项全国退伍军人健康管理局队列研究。
Drug Alcohol Depend. 2022 Dec 1;241:109678. doi: 10.1016/j.drugalcdep.2022.109678. Epub 2022 Nov 1.
5
Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.在 COVID-19 大流行期间，视频、电话和面对面使用丁丙诺啡治疗阿片类药物使用障碍的情况和保留率。
JAMA Netw Open. 2022 Oct 3;5(10):e2236298. doi: 10.1001/jamanetworkopen.2022.36298.
6
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic.在 COVID-19 大流行期间为弱势群体调整低门槛丁丙诺啡项目。
J Addict Med. 2021;15(5):364-369. doi: 10.1097/ADM.0000000000000774.
7
The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study.新冠疫情对监狱设施中阿片类物质使用障碍治疗的影响：一项横断面研究。
Health Justice. 2022 Dec 19;10(1):35. doi: 10.1186/s40352-022-00199-1.
8
Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.COVID-19 大流行期间阿片类药物使用障碍的阿片类镇痛药和丁丙诺啡的处方
JAMA Netw Open. 2021 Apr 1;4(4):e216147. doi: 10.1001/jamanetworkopen.2021.6147.
9
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.COVID-19 对使用阿片类药物人群的医疗服务提供的影响：范围综述。
Subst Abuse Treat Prev Policy. 2021 Aug 9;16(1):60. doi: 10.1186/s13011-021-00395-6.
10
Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program.在 COVID-19 大流行期间利用远程医疗为基于街头的低门槛丁丙诺啡项目提供服务。
Drug Alcohol Depend. 2022 Jan 1;230:109187. doi: 10.1016/j.drugalcdep.2021.109187. Epub 2021 Nov 26.
引用本文的文献
1
Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments.基于远程医疗的阿片类药物使用障碍药物辅助治疗的实施：近期发展的批判性回顾。
Curr Psychiatry Rep. 2022 Sep;24(9):375-386. doi: 10.1007/s11920-022-01346-z. Epub 2022 Jul 27.
本文引用的文献
1
Buprenorphine Program Evaluation in a Private Psychiatric Office-Based Practice.私人精神科门诊中丁丙诺啡项目的评估。
J Addict Nurs. 2023;34(1):89-95. doi: 10.1097/JAN.0000000000000516.
2
Therapists Make the Switch to Telepsychology to Safely Continue Treating Their Patients During the COVID-19 Pandemic. Virtual Reality Telepsychology May Be Next.在新冠疫情期间，治疗师转向远程心理治疗以安全地继续为患者提供治疗。虚拟现实远程心理治疗可能是下一步发展方向。
Front Virtual Real. 2021 Jan;1. doi: 10.3389/frvir.2020.576421. Epub 2021 Jan 15.
3
Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment.患者对通过远程医疗治疗阿片类药物使用障碍药物的满意度：简要文献综述及新评估方法的制定。
Front Public Health. 2021 Jan 21;8:557275. doi: 10.3389/fpubh.2020.557275. eCollection 2020.
4
Drug Overdose Deaths in the United States, 1999-2019.美国 1999-2019 年药物过量死亡人数。
NCHS Data Brief. 2020 Dec(394):1-8.
5
The COVID-19 telepsychology revolution: A national study of pandemic-based changes in U.S. mental health care delivery.新冠疫情下的远程心理学革命：基于全美范围的研究，探讨大流行期间美国心理健康服务提供模式的变化。
Am Psychol. 2021 Jan;76(1):14-25. doi: 10.1037/amp0000722. Epub 2020 Aug 20.
6
Opioid Use Disorder and COVID-19: Crashing of the Crises.阿片类药物使用障碍与 COVID-19：危机的碰撞。
J Addict Med. 2020 Jul/Aug;14(4):e6-e7. doi: 10.1097/ADM.0000000000000684.
7
Medication-Assisted Treatment for Opioid-Use Disorder.阿片类物质使用障碍的药物辅助治疗。
Mayo Clin Proc. 2019 Oct;94(10):2072-2086. doi: 10.1016/j.mayocp.2019.03.029. Epub 2019 Sep 19.
8
Identifying and addressing mental health providers' perceived barriers to clinical video telehealth utilization.识别和解决精神健康服务提供者在临床视频远程医疗利用方面的感知障碍。
J Clin Psychol. 2020 Jun;76(6):1125-1134. doi: 10.1002/jclp.22770. Epub 2019 Mar 11.
9
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.酒精和阿片类药物使用障碍的药物治疗与自杀行为、意外过量用药和犯罪的风险。
Am J Psychiatry. 2018 Oct 1;175(10):970-978. doi: 10.1176/appi.ajp.2018.17101112. Epub 2018 Aug 2.
10
The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017.滥用处方阿片类药物的经济负担：2012 年至 2017 年的系统文献综述。
Appl Health Econ Health Policy. 2018 Oct;16(5):609-632. doi: 10.1007/s40258-018-0402-x.
Zotero 插件